Insiders · Profile

Brady Stephen R

President and CEO at Tempest Therapeutics. Filing since 3 Jul 2024. CIK 0001606241

Company

Date

Role

Action

Shares

Amount

Of holding

TPST Tempest Therapeutics, Inc.

3 Jul 2024

President and CEO

Bought

35,000

$73.85K

308%

1 decision on file.